Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for 6-thioguanine (6-TG)

4 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCPED16131

    04/30/2018

    A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic Leukemia

    Treatment

    COGAAML1531

    08/23/2016

    Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome

    Treatment

    COGAALL1331

    02/01/2016

    Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

    Treatment

    COGAALL1131

    04/05/2012

    A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND #73789, NSC# 606869) in the Very High Risk Stratum


    Print this page for your doctor